Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Arteaga

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Biological Chemistry|March 7, 1997
Processing of the transforming growth factor beta type I and II receptors. Biosynthesis and ligand-induced regulationK M Koli, C L Arteaga
Cancer Research|November 15, 1989
Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptorC L Arteaga, C K Osborne
Cancer Research|March 1, 1997
Predominant cytosolic localization of type II transforming growth factor beta receptors in human breast carcinoma cellsK M Koli, C L Arteaga
Investigational New Drugs|July 1, 1989
Inefficacy of methylglyoxal bis(guanylhydrazone) (MGBG) in patients with recurrent head and neck squamous cell carcinomaC L Arteaga, G M Clark
Breast Cancer Research and Treatment|January 1, 1990
Autocrine and paracrine growth regulation of breast cancer: clinical implicationsC K Osborne, C L Arteaga
Cancer Research|March 1, 1996
Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude miceC L Arteaga, J T Holt
Human Pathology|January 1, 1992
Transforming growth factor-beta isoforms in mammary neoplasia: more questions than answersC L Arteaga, R J Coffey
Seminars in Oncology|March 10, 2001
HER-2/neu (erbB-2) and the cell cycleD Busse, R S Doughty, C L Arteaga
Molecular Endocrinology (Baltimore, Md.)|November 1, 1988
Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancerC L Arteaga, E Coronado, C K Osborne
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogensC K Osborne, L Kitten, C L Arteaga
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|March 7, 1997
Processing of the transforming growth factor beta type I and II receptors. Biosynthesis and ligand-induced regulationK M Koli, C L Arteaga
Cancer Research|November 15, 1989
Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptorC L Arteaga, C K Osborne
Cancer Research|March 1, 1997
Predominant cytosolic localization of type II transforming growth factor beta receptors in human breast carcinoma cellsK M Koli, C L Arteaga
Investigational New Drugs|July 1, 1989
Inefficacy of methylglyoxal bis(guanylhydrazone) (MGBG) in patients with recurrent head and neck squamous cell carcinomaC L Arteaga, G M Clark
Breast Cancer Research and Treatment|January 1, 1990
Autocrine and paracrine growth regulation of breast cancer: clinical implicationsC K Osborne, C L Arteaga
Cancer Research|March 1, 1996
Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude miceC L Arteaga, J T Holt
Human Pathology|January 1, 1992
Transforming growth factor-beta isoforms in mammary neoplasia: more questions than answersC L Arteaga, R J Coffey
Seminars in Oncology|March 10, 2001
HER-2/neu (erbB-2) and the cell cycleD Busse, R S Doughty, C L Arteaga
Molecular Endocrinology (Baltimore, Md.)|November 1, 1988
Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancerC L Arteaga, E Coronado, C K Osborne
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogensC K Osborne, L Kitten, C L Arteaga
Pageof 9